Tracy Staton
Perrigo has snatched up Elan for $ 8.6 billion in a cash-and-stock deal. Call it a case of opposites attracting: U.S.-based Perrigo specializes in cheap, store-brand generics, ...
Tracy Staton
A U.S. appeals court invalidated a patent protecting Copaxone till 2015–and that means Teva could face generic competition for its biggest drug next May.
FiercePharma ...
mia.burns
Forest Laboratories and Pierre Fabre Laboratories Announce FDA Approval of FETZIMA™ for the Treatment of Major Depressive Disorder in Adults
NEW YORK & CASTRES, ...
barbara.lempert
Largest PCMH program in the nation yields improvements in quality and preventive care
DETROIT, July 8, 2013 /PRNewswire/ — Blue Cross Blue Shield of Michigan ...
mia.burns
By Mia Burns
Healthcare industry executives’ understanding of the need to collaborate and the challenges they face in working together are explored in a new report from ...
Carly Helfand
Novartis' Bexsero may be the only vaccine approved for life-threatening meningitis B, but that wasn't enough to convince the U.K.'s Joint Committee on Vaccination ...
Ryan McBride
Harbour Antibodies has added to a list of pharma partners for its transgenic mouse technology for producing human antibodies. Pfizer has licensed the company's mice ...
esilverman
Hello, everyone, and nice to see you again. As you can see, we have returned from an extended weekend during which we accomplished several things on our to-do list. ...
barbara.lempert
Reports Phase 2 Data on ISIS-APOCIII Rx Showing Significant Reductions of ApoC-III and Triglycerides in Patients With High Triglycerides Taking Fibrates Reductions ...
esilverman
Three days after the US Department of Justice formally joined a whistleblower lawsuit against Mallinckrodt, the drugmaker has agreed to pay $ 3.5 million to settle ...
barbara.lempert
Par Pharmaceutical Begins Shipment of Generic Trilipix®
WOODCLIFF LAKE, N.J., July 18, 2013 /PRNewswire/ — Par Pharmaceutical Companies, Inc. today announced ...
John Carroll
Alzheimer's was in the spotlight this week as investigators gathered at the annual Alzheimer's Association International Conference in Boston to ponder the latest ...